Phase 1 study of TRU-016, an anti-CD37 SMIP™ protein in Naïve and relapsed and/or refractory CLL patients

The requested reference [d6c92e029ceebed1e0edf83205562f3a10e3d056] no longer exists in our database. It has been replaced by the current reference: [400eac5c139c64b9acdf26c3aae47f2728a97be6]

Authors
Category Primary study
JournalBlood
Year 2011
This article has no abstract
Epistemonikos ID: c2a9e42007388332116047b44c60fd6d2101cad9
First added on: Feb 05, 2025